Create MedicCREATE MEDIC CO.,LTD.5187東証スタンダード精密機器FY ending Dec 2025, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥7 is left as operating profit. Revenue changed +4.5% from the prior year, operating profit +45.1%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2021 | 5.6% | 0.65× | 3.7% | 1.35× | 4.9% |
| 2022 | 3.9% | 0.67× | 2.6% | 1.39× | 3.6% |
| 2023 | 1.2% | 0.66× | 0.8% | 1.45× | 1.2% |
| 2024 | 6.5% | 0.66× | 4.3% | 1.51× | 6.5% |
| 2025 | 5.2% | 0.68× | 3.6% | 1.53× | 5.4% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 11,699 | 12,327 | 12,585 | 13,030 | 13,618 |
| Cost of revenue | 6,438 | 6,931 | 7,107 | 7,326 | 7,624 |
| Gross profit | 5,260 | 5,395 | 5,478 | 5,704 | 5,994 |
| SG&A | 4,393 | 4,654 | 4,675 | 5,012 | 4,989 |
| Operating income | 867 | 741 | 803 | 692 | 1,005 |
| Pretax income | 966 | 863 | 904 | 1,087 | 1,061 |
| Income tax | 305 | 381 | 750 | 246 | 347 |
| Net income attributable to owners | 660 | 482 | 154 | 841 | 714 |
| Operating margin | 7.4% | 6.0% | 6.4% | 5.3% | 7.4% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥3.41B | ¥3.7B | ¥3.77B | ¥5.66B | ¥5.06B |
| Total assets | ¥18.1B | ¥18.9B | ¥19.3B | ¥20B | ¥20.1B |
| Net assets | ¥14.2B | ¥14.7B | ¥14.9B | ¥15.8B | ¥16.3B |
| Share capital | ¥1.46B | ¥1.46B | ¥1.46B | ¥1.46B | ¥1.46B |
| Trade receivables | ¥2.31B | — | — | — | — |
| Property, plant and equipment | ¥5.08B | ¥5.16B | ¥5.39B | ¥4.84B | ¥4.71B |
| Intangible assets excluding goodwill | ¥686.7M | ¥636.9M | ¥565.7M | ¥532.1M | ¥418.7M |
| Investment securities | ¥394M | ¥547.7M | ¥454.3M | ¥619.5M | ¥669.9M |
| Current assets | ¥11.6B | ¥12.1B | ¥12.7B | ¥13.9B | ¥14.2B |
| Current liabilities | ¥2.57B | ¥2.82B | ¥2.97B | ¥3.11B | ¥2.02B |
| Trade payables | ¥451M | ¥487.5M | ¥498.8M | ¥534.8M | ¥460.3M |
| Short-term borrowings | ¥800M | ¥800M | ¥800M | ¥800M | — |
| Total liabilities | ¥3.86B | ¥4.14B | ¥4.31B | ¥4.3B | ¥3.81B |
| Equity attributable to owners of parent | ¥13.4B | ¥13.2B | ¥13B | ¥13B | ¥13.2B |
| Retained earnings | ¥10.9B | ¥10.8B | ¥10.6B | ¥11.1B | ¥11.5B |
| Treasury stock | -¥514M | -¥509.9M | -¥506.1M | -¥1B | -¥1.2B |
EDINET (FSA Japan)
有価証券報告書－第52期(2025/01/01－2025/12/31)
EDINET (FSA Japan)
有価証券報告書－第51期(2024/01/01－2024/12/31)
EDINET (FSA Japan)
有価証券報告書－第50期(2023/01/01－2023/12/31)
EDINET (FSA Japan)
有価証券報告書－第49期(2022/01/01－2022/12/31)
EDINET (FSA Japan)
有価証券報告書－第48期(令和3年1月1日－令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書－第47期(令和2年1月1日－令和2年12月31日)
Extracted from XBRL: 50 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.